SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 273-279

  Loh, Tiing Jen ^a   Moon, Heegyum ^a   Cho, Sunghee ^a   Jung, Da Woon ^a   Hong, Seong Eui ^a   Kim, Do Han ^a   Green, Michael R ^b   Zheng, Xuexiu ^a   Zhou, Jianhua ^c   Shen, Haihong ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c NANTONG UNIVERSITY   (China)

Author keywords

Cancer; CD44; Pre mRNA splicing; SC35; V6 exon

Indexed keywords

GREEN FLUORESCENT PROTEIN; HERMES ANTIGEN; MESSENGER RNA PRECURSOR; PROTEIN SC35; RED FLUORESCENT PROTEIN; SERINE ARGININE RICH PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; EXON SKIPPING; GENE SILENCING; GENETIC REGULATION; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANTIGENS, CD44; CELL LINE, TUMOR; HUMANS; MCF-7 CELLS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; RIBONUCLEOPROTEINS; RNA INTERFERENCE; RNA PRECURSORS; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84891913321     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2812     Document Type: Article

References (42)

1. Bourguignon LY: CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia 6: 287-297, 2001.
2. Zoller M: CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11: 254-267, 2011.
3. Marhaba R and Zoller M: CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35: 211-231, 2004.
4. Herrlich P, Morrison H, Sleeman J, et al: CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann NY Acad Sci 910: 106-120, 2000.
5. Screaton GR, Bell MV, Bell JI and Jackson DG: The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 268: 12235-12238, 1993.
6. Herrera-Gayol A and Jothy S: Adhesion proteins in the biology of breast cancer: contribution of CD44. Exp Mol Pathol 66: 149-156, 1999.
7. Gunthert U, Hofmann M, Rudy W, et al: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24, 1991.
8. Rudy W, Hofmann M, Schwartz-Albiez R, et al: The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res 53: 1262-1268, 1993.
9. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H and Herrlich P: CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619, 1995.
10. Tempfer C, Losch A, Heinzl H, et al: Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. Eur J Cancer 32A: 2023-2025, 1996.
11. Sinn HP, Heider KH, Skroch-Angel P, et al: Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Breast Cancer Res Treat 36: 307-313, 1995.
12. Reber S, Matzku S, Gunthert U, Ponta H, Herrlich P and Zoller M: Retardation of metastatic tumor growth after immunization with metastasis-specific monoclonal antibodies. Int J Cancer 46: 919-927, 1990.
13. Seiter S, Arch R, Reber S, et al: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177: 443-455, 1993.
14. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P and Ponta H: CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 16: 3074-3086, 2002.
15. Recio JA and Merlino G: Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1. Cancer Res 63: 1576-1582, 2003.
16. Cheng C, Yaffe MB and Sharp PA: A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev 20: 1715-1720, 2006.
17. Tsukita S, Oishi K, Sato N, Sagara J and Kawai A: ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 126: 391-401, 1994.
18. Legg JW and Isacke CM: Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr Biol 8: 705-708, 1998.
19. Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T and Tsukita S: Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 140: 885-895, 1998.
20. Wahl MC, Will CL and Luhrmann R: The spliceosome: design principles of a dynamic RNP machine. Cell 136: 701-718, 2009.
21. Cooper TA, Wan L and Dreyfuss G: RNA and disease. Cell 136: 777-793, 2009.
22. Xu Q and Lee C: Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Res 31: 5635-5643, 2003.
23. Kim E, Goren A and Ast G: Insights into the connection between cancer and alternative splicing. Trends Genet 24: 7-10, 2008.
24. Venables JP, Klinck R, Bramard A, et al: Identification of alternative splicing markers for breast cancer. Cancer Res 68: 9525-9531, 2008.
25. Black DL: Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72: 291-336, 2003.
26. Shen H, Zheng X, Luecke S and Green MR: The U2AF35-related protein Urp contacts the 3′ splice site to promote U12-type intron splicing and the second step of U2-type intron splicing. Genes Dev 24: 2389-2394, 2010.
27. Konig H, Moll J, Ponta H and Herrlich P: Trans-acting factors regulate the expression of CD44 splice variants. EMBO J 15: 4030-4039, 1996.
28. Cho S, Moon H, Yang X, et al: Validation of trans-acting elements that promote exon 7 skipping of SMN2 in SMN2-GFP stable cell line. Biochem Biophys Res Commun 423: 531-535, 2012.
29. Lee J, Zhou J, Zheng X, et al: Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA. Biochem Biophys Res Commun 420: 467-472, 2012.
30. Busch A and Hertel KJ: Evolution of SR protein and hnRNP splicing regulatory factors. Wiley Interdiscip Rev RNA 3: 1-12, 2012.
31. Hertel KJ: Combinatorial control of exon recognition. J Biol Chem 283: 1211-1215, 2008.
32. Senapathy P, Shapiro MB and Harris NL: Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol 183: 252-278, 1990.
33. Shen H and Green MR: RS domain-splicing signal interactions in splicing of U12-type and U2-type introns. Nat Struct Mol Biol 14: 597-603, 2007.
34. Zhong XY, Wang P, Han J, Rosenfeld MG and Fu XD: SR proteins in vertical integration of gene expression from transcription to RNA processing to translation. Mol Cell 35: 1-10, 2009.
35. Stoilov P, Lin CH, Damoiseaux R, Nikolic J and Black DL: A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators. Proc Natl Acad Sci USA 105: 11218-11223, 2008.
36. van Weering DH, Baas PD and Bos JL: A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl 3: 100-106, 1993.
37. Cartegni L, Wang J, Zhu Z, Zhang MQ and Krainer AR: ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31: 3568-3571, 2003.
38. Hernandez F, Perez M, Lucas JJ, Mata AM, Bhat R and Avila J: Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease. J Biol Chem 279: 3801-3806, 2004.
39. D'Souza I and Schellenberg GD: Determinants of 4-repeat tau expression. Coordination between enhancing and inhibitory splicing sequences for exon 10 inclusion. J Biol Chem 275: 17700-17709, 2000.
40. Graveley BR: Sorting out the complexity of SR protein functions. RNA 6: 1197-1211, 2000.
41. Lin S, Coutinho-Mansfield G, Wang D, Pandit S and Fu XD: The splicing factor SC35 has an active role in transcriptional elongation. Nat Struct Mol Biol 15: 819-826, 2008.
42. Qian W, Iqbal K, Grundke-Iqbal I, Gong CX and Liu F: Splicing factor SC35 promotes tau expression through stabilization of its mRNA. FEBS Lett 585: 875-880, 2011.